{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:48:00Z","timestamp":1791247680243,"version":"4.1.0"},"reference-count":121,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A growing body of evidence support the association between the use of hormone replacement therapy (HRT) and a higher risk of both invasive lobular carcinoma (ILC) and invasive ductal\u2013lobular mixed carcinoma (IDLC). Overall biological and clinical features of ILC entail a more cautious diagnostic and therapeutic approach as compared with invasive ductal carcinoma (IDC). ILCs are more frequently multifocal, multicentric and\/or bilateral. Mammography and ultrasound show, therefore, significant limitations, while the higher sensitivity of magnetic resonance imaging in the detection of multifocal and\/or multicentric lesions seems to improve the accuracy of preoperative staging of ILCs. Early diagnosis is even more challenging because the difficult in the localization and the sparse cellularity of lobular tumours may determine a false negative core biopsy. ILC is characterized by low proliferative activity, C-ErbB-2 negativity, bcl-2 positivity, p53 and VEGF negativity, oestrogen and progesterone positive receptors, low grade and low likelihood of lymphatic-vascular invasion. However, this more favourable biological behaviour does not reflect into a better disease-free and overall survival as compared with IDC. Since lobular histology is associated with a higher risk of positive margins, mastectomy is often preferred to breast conservative surgery. Moreover, only few patients with ILC achieve a pathologic response to preoperative chemotherapy and, therefore, in most patients mastectomy can be regarded as the safer surgical treatment. The preoperative staging and the follow-up of patients with ILC are also complicated by the particular metastatic pattern of such histotype. In fact, metastases are more frequently distributed to the gastrointestinal tract, peritoneum\/retroperitoneum and gynaecological organs than in IDC.<\/jats:p>","DOI":"10.1677\/erc-06-0060","type":"journal-article","created":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T19:03:02Z","timestamp":1191438182000},"page":"549-567","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":77,"title":["Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment"],"prefix":"10.1530","volume":"14","author":[{"given":"Nicoletta","family":"Biglia","sequence":"first","affiliation":[{"name":"Academic Department of Gynaecological Oncology, Mauriziano Umberto I\u00b0 Hospital of Turin and Institute for Cancer Research and Treatment of Candiolo, University of Turin, Largo Turati 62, 10129 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mariani","sequence":"additional","affiliation":[{"name":"Academic Department of Gynaecological Oncology, Mauriziano Umberto I\u00b0 Hospital of Turin and Institute for Cancer Research and Treatment of Candiolo, University of Turin, Largo Turati 62, 10129 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sgro","sequence":"additional","affiliation":[{"name":"Academic Department of Gynaecological Oncology, Mauriziano Umberto I\u00b0 Hospital of Turin and Institute for Cancer Research and Treatment of Candiolo, University of Turin, Largo Turati 62, 10129 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Mininanni","sequence":"additional","affiliation":[{"name":"Academic Department of Gynaecological Oncology, Mauriziano Umberto I\u00b0 Hospital of Turin and Institute for Cancer Research and Treatment of Candiolo, University of Turin, Largo Turati 62, 10129 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Moggio","sequence":"additional","affiliation":[{"name":"Academic Department of Gynaecological Oncology, Mauriziano Umberto I\u00b0 Hospital of Turin and Institute for Cancer Research and Treatment of Candiolo, University of Turin, Largo Turati 62, 10129 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Sismondi","sequence":"additional","affiliation":[{"name":"Academic Department of Gynaecological Oncology, Mauriziano Umberto I\u00b0 Hospital of Turin and Institute for Cancer Research and Treatment of Candiolo, University of Turin, Largo Turati 62, 10129 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2026070906041704700_ABD-EL-REHIM-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Abd El-Rehim\n            DM\n          , Pinder SE, Paish CE, Bell JA, Rampaul RS, Blamey RW, Robertson JFR, Nicholson RI & Ellis IO 2004 Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. British Journal of Cancer911532\u20131542.","DOI":"10.1038\/sj.bjc.6602184"},{"key":"2026070906041704700_ALLEMANI-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Allemani\n            C\n          , Sant M, Berrino F, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Contiero P, Danzon A & Federico M 2004 Prognostic value of morphology and hormone receptor status in breast cancer \u2013 a population-based study. British Journal of Cancer911263\u20131268.","DOI":"10.1038\/sj.bjc.6602153"},{"key":"2026070906041704700_ANDERSON-ETAL-2004","unstructured":"Anderson\n            GL\n          , Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B & Women\u2019s Health Initiative Steering Committee 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial. JAMA2911701\u20131712."},{"key":"2026070906041704700_ARPINO-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Arpino\n            G\n          , Bardou VJ, Clark GM & Elledge RM 2004 Infiltrating lobular carcinoma of the breast:tumor characterictcs and clinical outcome. Breast Cancer Research6149\u2013156.","DOI":"10.1186\/bcr767"},{"key":"2026070906041704700_BAMIAS-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Bamias\n            A\n          , Baltayiannis G, Kamina S, Fatouros M, Lymperopoulos E, Agnanti N, Tsianos E & Pavlidis N 2001 Rectal metastases from lobular carcinoma of the breast: report of a case and literature review. Annals of Oncology12715\u2013718.","DOI":"10.1023\/A:1011192827710"},{"key":"2026070906041704700_BEDROSIAN-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Bedrosian\n            I\n          , Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR, Callans LS, Buzby GP, Rosato EF & Fraker DL 2003 Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer98468\u2013473.","DOI":"10.1002\/cncr.11490"},{"key":"2026070906041704700_BERAL-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Beral\n            V\n           & Million Women Study Collaborators 2003 Breast cancer and hormone replacement therapy in the Million Women Study. Lancet362419\u2013427.","DOI":"10.1016\/S0140-6736(03)14596-5"},{"key":"2026070906041704700_BIGLIA-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Biglia\n            N\n          , Sgro L, Defabiani E, De Rosa G, Ponzone R, Marenco D & Sismondi P 2005 The influence of hormone replacement therapy on the pathology of breast cancer. European Journal of Surgical Oncology31467\u2013472.","DOI":"10.1016\/j.ejso.2005.02.005"},{"key":"2026070906041704700_BOETES-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Boetes\n            C\n          , Veltman J, Van Die L, Bult P, Wobbes T & Barentsz JO 2004 The role of MRI in invasive lobular carcinoma. Breast Cancer Research and Treatment3631\u201337.","DOI":"10.1023\/B:BREA.0000032921.10481.dc"},{"key":"2026070906041704700_BORST-AND-INGOLD-1993","unstructured":"Borst\n            MJ\n           & Ingold JA 1993 Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery114637\u2013641."},{"key":"2026070906041704700_BOUVET-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Bouvet\n            M\n          , Ollila DW, Hunt KK, Babiera GV, Spitz FR, Giuliano AE, Strom EA, Ames FC, Ross MI & Singletary SE 1997 Role of conservation therapy for invasive lobular carcinoma of the breast. Annals of Surgical Oncology4650\u2013654.","DOI":"10.1007\/BF02303750"},{"key":"2026070906041704700_BUMPERS-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Bumpers\n            HL\n          , Hassett JM Jr, Penetrante RB, Hoover EL & Holyoke ED 1993 Endocrine organ metastases in subjects with lobular carcinoma of the breast. Archives of Surgery1281344\u20131347.","DOI":"10.1001\/archsurg.1993.01420240052009"},{"key":"2026070906041704700_BUTLER-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Butler\n            RS\n          , Venta LA, Wiley EL, Ellis RL, Dempsey PJ & Rubin E 1999 Sonographic evaluation of infiltrating lobular carcinoma. American Journal of Roentgenology172325\u2013330.","DOI":"10.2214\/ajr.172.2.9930776"},{"key":"2026070906041704700_CALY-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Caly\n            M\n          , Genin P, Ghuzlan AA, Elie C, Freneaux P, Klijanienko J, Rosty C, Sigal-Zafrani B, Vincent-Salomon A & Douggaz A 2004 Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 cases. Anticancer Research243283\u20133288.","DOI":"10.1016\/S0242-6498(05)80125-7"},{"key":"2026070906041704700_CHAGPAR-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Chagpar\n            A\n          , Martin RCG II, Hagerndoorn LJ, Chao BSC & McMasters KM 2004 Lumpectomy margins are affected by tumour size and histologic subtype but not by biopsy technique. American Journal of Surgery188399\u2013402.","DOI":"10.1016\/j.amjsurg.2004.06.020"},{"key":"2026070906041704700_CHEN-ETAL-2002","unstructured":"Chen\n            CL\n          , Weiss NS, Newcomb P, Barlow W & White E 2002 Hormone replacement therapy in relation to breast cancer. JAMA287734\u2013741."},{"key":"2026070906041704700_CHEN-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Chen\n            WY\n          , Manson JE, Hankinson SE, Rosner B, Holmes MD, Willett WC & Colditz GA 2006 Unopposed estrogen therapy and the risk of invasive breast cancer. Archives of Internal Medicine1661027\u20131032.","DOI":"10.1001\/archinte.166.9.1027"},{"key":"2026070906041704700_CHINTANA-ETAL-1995","unstructured":"Chintana\n            PP\n          , Helvie MA & Adler DD 1995 Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology195231\u2013234."},{"key":"2026070906041704700_CHUNG-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Chung\n            MA\n          , Cole B, Wanebo HJ, Bland KI & Chang HR 1997 Optimal surgical treatment of invasive lobular carcinoma of the breast. Annals of Surgical Oncology20545\u2013550.","DOI":"10.1007\/BF02305534"},{"key":"2026070906041704700_CLASSE-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Classe\n            JM\n          , Loussouarn D, Campion L, Fiche M, Curtet C, Dravet F, Pioud R, Rousseau C, Resche I & Sagan C 2004 Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study. Cancer100935\u2013941.","DOI":"10.1002\/cncr.20054"},{"key":"2026070906041704700_COCQUYT-AND-VAN-BELLE-2005","doi-asserted-by":"crossref","unstructured":"Cocquyt\n            V\n           & Van Belle S 2005 Lobular carcinoma in situ and invasive lobular cancer of the breast. Current Opinion in Obstetrics and Gynecology1755\u201360.","DOI":"10.1097\/00001703-200502000-00010"},{"key":"2026070906041704700_COCQUYT-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Cocquyt\n            VF\n          , Blondeel PN, Depypere HT, Praet MM, Schelfhout VR, Silva OE, Hurley J, Serreyn RF, Daems KK & Van Belle SJ 2003 Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma. European Journal of Surgical Oncology29361\u2013367.","DOI":"10.1053\/ejso.2002.1404"},{"key":"2026070906041704700_COLDITZ-AND-ROSNER-1998","unstructured":"Colditz\n            GA\n           & Rosner B 1998 Use of estrogen plus progestin is associated with greater increase in breast cancer risk than estrogen alone. American Journal of Epidemiology14764S."},{"key":"2026070906041704700_COLDITZ-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Colditz\n            GA\n          , Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B & Speizer FE 1995 The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New England Journal of Medicine3321589\u20131593.","DOI":"10.1056\/NEJM199506153322401"},{"key":"2026070906041704700_CORADINI-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Coradini\n            D\n          , Pellizzaro C, Veneroni S, Ventura L & Daidone MG 2002 Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence. British Journal of Cancer871105\u20131111.","DOI":"10.1038\/sj.bjc.6600556"},{"key":"2026070906041704700_CORNFORD-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Cornford\n            EJ\n          , Wilson AR, Athanassiou 4E, Galea M, Ellis IO, Elston CW & Blamey RW 1995 Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analyisis. British Journal of Radiology68450\u2013453.","DOI":"10.1259\/0007-1285-68-809-450"},{"key":"2026070906041704700_CREAGER-AND-GEISINGER-2002","doi-asserted-by":"crossref","unstructured":"Creager\n            AJ\n           & Geisinger KR 2002 Intraoperative evaluation of sentinel lymph nodes for breast carcinoma: current methodologies. Advances in Anatomic Pathology9233\u2013243.","DOI":"10.1097\/00125480-200207000-00003"},{"key":"2026070906041704700_CRISTOFANILLI-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Cristofanilli\n            M\n          , Gonzalez-Angulo A, Sneige N, Kau SW, Broglio K, Theriault RL, Valero V, Buzdar AU, Kuerer H & Buccholz TA 2005 Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. Journal of Clinical Oncology2341\u201348.","DOI":"10.1200\/JCO.2005.03.111"},{"key":"2026070906041704700_DALING-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Daling\n            JR\n          , Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK & Ursin G 2002 Relation of regimens of combined hormone replacement therapy to lobular,ductal, and other histologic types of breast carcinoma. Cancer952455\u20132464.","DOI":"10.1002\/cncr.10984"},{"key":"2026070906041704700_VAN-DIEST-ETAL-2004","unstructured":"van Diest\n            PJ\n          , van der Wall E & Baak JP 2004 Prognostic value of proliferation in invasive breast cancer: a review. Journal of Clinical Pathology57675\u2013681."},{"key":"2026070906041704700_DIXON-ETAL-1982","unstructured":"Dixon\n            JM\n          , Anderson TJ, Page DL, Lee D & Duffy SW 1982 Infiltrating lobular carcinoma of the breast. Histopathology6149\u2013161."},{"key":"2026070906041704700_DU-TOIT-ETAL-1991","unstructured":"Du Toit\n            RS\n          , Cocker AP, Ellis IO, Elston CW, Nicholson RL, Robertson JFR & Blamey RW 1991 An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. European Journal of Surgical Oncology17251\u2013257."},{"key":"2026070906041704700_ESSERMAN-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Esserman\n            L\n          , Wolverton D & Hylton N 2002 Magnetic resonance imaging for primary breast cancer management: current role and new applications. Endocrine-Related Cancer9141\u2013153.","DOI":"10.1677\/erc.0.0090141"},{"key":"2026070906041704700_EVANS-AND-LYONS-2000","doi-asserted-by":"crossref","unstructured":"Evans\n            N\n           & Lyons K 2000 The use of ultrasound in the diagnosis of invasive lobular carcinoma of the breast less than 10 mm size. Clinical Radiology55261\u2013263.","DOI":"10.1053\/crad.1999.0291"},{"key":"2026070906041704700_EVANS-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Evans\n            WP\n          , Warren Burhenne LJ, Laurie L, O\u2019Shaughnessy KF & Castellino RA 2002 Invasive lobular carcinoma of the breast: mammographic characteristics and computer-aided detection. Radiology225182\u2013189.","DOI":"10.1148\/radiol.2251011029"},{"key":"2026070906041704700_FISHER-ETAL-1975","doi-asserted-by":"crossref","unstructured":"Fisher\n            ER\n          , Gregorio RM, Fisher B, Redmond C, Vellios F & Sommers SC 1975 The pathology of invasive breast cancer: a syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol No. 4). Cancer361\u201385.","DOI":"10.1002\/1097-0142(197507)36:1<1::AID-CNCR2820360102>3.0.CO;2-4"},{"key":"2026070906041704700_FISHER-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Fisher\n            U\n          , Kopka L & Grabbe E 1999 Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology213881\u2013888.","DOI":"10.1148\/radiology.213.3.r99dc01881"},{"key":"2026070906041704700_FLEMING-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Fleming\n            FJ\n          , Hill AD, Mc Dermott EW, O\u2019Doherty A, O\u2019Higgins NJ & Quinn CM 2004 Intraoperative margin assessment and re-excision rate in breast conserving surgery. European Journal of Surgical Oncology30233\u2013237.","DOI":"10.1016\/j.ejso.2003.11.008"},{"key":"2026070906041704700_FROLIK-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Frolik\n            D\n          , Caduff R & Varga Z 2001 Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. Histopathology39503\u2013513.","DOI":"10.1046\/j.1365-2559.2001.01252.x"},{"key":"2026070906041704700_LE-GAL-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Le Gal\n            M\n          , Ollivier L, Asselain B, Meunier M, Laurent M, Vielh P & Neuenschwander S 1992 Mammographic features of 455 invasive lobular carcinomas. Radiology185705\u2013708.","DOI":"10.1148\/radiology.185.3.1438749"},{"key":"2026070906041704700_GOLDFLAM-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Goldflam\n            K\n          , Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW et al.2004 Controlateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer1011977\u20131986.","DOI":"10.1002\/cncr.20617"},{"key":"2026070906041704700_GOLSHAN-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Golshan\n            M\n          , Fung BB, Wiley E, Wolfaman J, Rademaker A & Morrow M 2004 Prediction of breast cancer size by ultrasound, mammography and core biopsy. Breast13265\u2013271.","DOI":"10.1016\/j.breast.2004.05.005"},{"key":"2026070906041704700_GOYAL-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Goyal\n            A\n          , Newcombe RG, Mansel RE, Chetty U, Ell P, Fallowfield L, Kissin M, Sibbering M & ALMANAC Trialists Group 2004 Sentinel lymph node biopsy in patients with multifocal breast cancer. European Journal of Surgical Oncology30475\u2013479.","DOI":"10.1016\/j.ejso.2004.02.009"},{"key":"2026070906041704700_GREENDALE-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Greendale\n            GA\n          , Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T & Barrett-Connor E 1999 Effects of estrogen and estrogen\u2013progestin on mammographic parenchymal density. Post-menopausal Estrogen\/Progestin Interventions (PEPI) Investigators. Annals of Internal Medicine130262\u2013269.","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00003"},{"key":"2026070906041704700_GUPTA-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Gupta\n            A\n          , Deshpande CG & Badve S 2003 Role of E-cadherins in development of lymphatic tumor emboli. Cancer972341\u20132347.","DOI":"10.1002\/cncr.11332"},{"key":"2026070906041704700_GURKAN-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Gurkan\n            A\n          , Erdogan G, Erdogan O, Pestereli E, Ogus M, Karaveli S & Colak T 2004 Expression of c-erbB-2 and p53 in breast carcinoma patients: comparison with traditional prognostic factors and survival. Journal of International Medical Research32455\u2013464.","DOI":"10.1177\/147323000403200502"},{"key":"2026070906041704700_HAFFTY-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Haffty\n            BG\n          , Perrotta PL, Ward B, Moran M, Beinfield M & McKhann C 1997 Conservatively treated breast cancer: outcome by histological type. Breast Journal37\u201314.","DOI":"10.1111\/j.1524-4741.1997.tb00134.x"},{"key":"2026070906041704700_HELVIE-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Helvie\n            MA\n          , Paramagul C, Oberman HA & Adler DD 1993 Invasive lobular carcinoma: imaging features and clinical detection. Investigative Radiology28202\u2013207.","DOI":"10.1097\/00004424-199303000-00002"},{"key":"2026070906041704700_HEMMINKI-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Hemminki\n            E\n          , Kennedy DL, Baum C & McKinlay SM 1988 Prescribing of noncontraceptive estrogens and progestins in the United States, 1974\u20131986. American Journal of Public Health781479\u20131481.","DOI":"10.2105\/AJPH.78.11.1479"},{"key":"2026070906041704700_HOFSETH-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Hofseth\n            LJ\n          , Raafat AM, Osuch JR, Pathak DR, Slomski CA & Haslam SZ 1999 Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. Journal of Clinical Endocrinology and Metabolism844559\u20134565.","DOI":"10.1210\/jc.84.12.4559"},{"key":"2026070906041704700_HOLLAND-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Holland\n            PA\n          , Shah A, Howell A, Baildam AD & Bundred NJ 1995 Lobular carcinoma of the breast managed by breast-conserving therapy. British Journal of Surgery821364\u20131366.","DOI":"10.1002\/bjs.1800821023"},{"key":"2026070906041704700_HORIGUCHI-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Horiguchi\n            J\n          , Iino Y, Takei H, Maemura M, Yokoe T, Niibe H, Yamakawa M, Nakajima T, Oyama T & Morishita Y 1999 Surgical margin and breast recurrence after breast-conserving therapy. Oncology Reports6135\u2013138.","DOI":"10.3892\/or.6.1.135"},{"key":"2026070906041704700_HORST-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Horst\n            KC\n          , Smitt MC, Goffinet DR & Carlson RW 2005 Predictors of local recurrence after breast-conservation therapy. Clinical Breast Cancer5425\u2013438.","DOI":"10.3816\/CBC.2005.n.001"},{"key":"2026070906041704700_HUSSIEN-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Hussien\n            M\n          , Lioe TF, Finnegan J & Spence AJ 2003 Surgical treatment for invasive lobular carcinoma of the breast. Breast1223\u201335.","DOI":"10.1016\/S0960-9776(02)00182-0"},{"key":"2026070906041704700_HWANG-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Hwang\n            S\n          , Ioffe O, Lee I, Waisman J, Cangiarella J & Simsir A 2004 Cytologic diagnosis of invasive lobular carcinoma: factors associated with negative and equivocal diagnoses. Diagnostic Cytopathology3187\u201393.","DOI":"10.1002\/dc.20084"},{"key":"2026070906041704700_ISMAIL-ETAL-2003","unstructured":"Ismail\n            PM\n          , Asmato P, Solyal SM, DeMayo FJ, Coneely OM, O\u2019Malley BW & Lydon JP 2003 Progesterone involvement in breast development and tumorigenesis \u2013 as revealed by progesterone receptor \u2018knockout\u2019 and \u2018knockin\u2019 mouse models. Steroids68779\u2013787."},{"key":"2026070906041704700_JIMENO-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Jimeno\n            A\n          , Amador ML, Gonzalez-Cortijo L, Tornamira MV, Ropero S, Valentin V, Hornedo J, Cortes-Funes H & Colomer R 2004 Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma. Cancer1001833\u20131842.","DOI":"10.1002\/cncr.20204"},{"key":"2026070906041704700_KAUFMANN-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Kaufmann\n            M\n          , von Minckwitz G, Smith R, Valero V, Gianni L, Eiermann W, Howell A, Costa SD, Beuzeboc P & Untch M 2003 International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. Journal of Clinical Oncology212600\u20132608.","DOI":"10.1200\/JCO.2003.01.136"},{"key":"2026070906041704700_KNEESHAW-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Kneeshaw\n            PJ\n          , Turnbull LW, Smith A & Drew PJ 2003 Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. European Journal of Surgical Oncology2932\u201337.","DOI":"10.1053\/ejso.2002.1391"},{"key":"2026070906041704700_KORHONEN-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Korhonen\n            T\n          , Huhtala H & Holli K 2004 A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast. Breast Cancer Research and Treatment8523\u201329.","DOI":"10.1023\/B:BREA.0000021038.97593.8b"},{"key":"2026070906041704700_KRECKE-AND-GISVOLD-1993","doi-asserted-by":"crossref","unstructured":"Krecke\n            KN\n           & Gisvold JJ 1993 Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. American Journal of Roentgenology161957\u2013960.","DOI":"10.2214\/ajr.161.5.8273634"},{"key":"2026070906041704700_KURTZ-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Kurtz\n            JM\n          , Jacquemier J, Torhorst J, Spitalier JM, Amalric R, Hunig R, Walther E, Harder F, Almendral A & Brandone H 1989 Conservation therapy for breast cancers other than infiltrating duct carcinoma. Cancer631630\u20131635.","DOI":"10.1002\/1097-0142(19890415)63:8<1630::AID-CNCR2820630833>3.0.CO;2-U"},{"key":"2026070906041704700_LAGENDIJK-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Lagendijk\n            JH\n          , Mullink H, van Diest PJ, Meijer GA & Meijer CJ 1999 Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. Journal of Clinical Pathology52283\u2013290.","DOI":"10.1136\/jcp.52.4.283"},{"key":"2026070906041704700_LEE-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Lee\n            JS\n          , Grant CS, Donohue JH, Crotty TB, Harmsen WS & Ilstrup DM 1995 Arguments against routine controlateral mastectomy or undirected biopsy for invasive lobular breast cancer. Surgery118640\u2013647.","DOI":"10.1016\/S0039-6060(05)80030-3"},{"key":"2026070906041704700_LI-ETAL-2000A","doi-asserted-by":"crossref","unstructured":"Li\n            CI\n          , Anderson BO, Porter P, Holt SK, Daling JR & Moe RE 2000a Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer882561\u20132569.","DOI":"10.1002\/1097-0142(20000601)88:11<2561::AID-CNCR19>3.0.CO;2-X"},{"key":"2026070906041704700_LI-ETAL-2000B","doi-asserted-by":"crossref","unstructured":"Li\n            CI\n          , Weiss NS, Stanford JL & Daling JR 2000b Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer882570\u20132577.","DOI":"10.1002\/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O"},{"key":"2026070906041704700_LI-ETAL-2003A","doi-asserted-by":"crossref","unstructured":"Li\n            CI\n          , Anderson BO, Daling JR & Moe RE 2003a Trend in incidence rates of invasive lobular and ductal breast carcinoma. JAMA2891421\u20131424.","DOI":"10.1001\/jama.289.11.1421"},{"key":"2026070906041704700_LI-ETAL-2003B","unstructured":"Li\n            CI\n          , Anderson BO, Verkooijen HM, Fioretta G, Vlastos G, Morabia A, Schubert H, Sappino A, Pelte M & Schafer P 2003b Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. International Journal of Cancer104778\u2013781."},{"key":"2026070906041704700_LI-ETAL-2003C","unstructured":"Li\n            CI\n          , Malone KE, Porter PL, Weiss NS, Tang MC, Cushing-Haughen KL & Daling JR 2003c Relationships between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA2893254\u20133263."},{"key":"2026070906041704700_LI-ETAL-2003D","doi-asserted-by":"crossref","unstructured":"Li\n            CI\n          , Moe RE & Daling JR 2003d Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Archives of Internal Medicine1632149\u20132153.","DOI":"10.1001\/archinte.163.18.2149"},{"key":"2026070906041704700_LINDERHOLM-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Linderholm\n            B\n          , Adersson J, Lindh B, Beckman L, Erlanson M, Edin K, Tavelin B, Grankvist K & Henriksson R 2004 Overexpression of c-erbB-2 is related to higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment. European Journal of Cancer4033\u201342.","DOI":"10.1016\/S0959-8049(03)00673-7"},{"key":"2026070906041704700_MAGNUSSON-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Magnusson\n            C\n          , Persson I & Adami HO 2000 More about: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Journal of the National Cancer Institute921183\u20131184.","DOI":"10.1093\/jnci\/92.14.1183"},{"key":"2026070906041704700_MAI-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Mai\n            KT\n          , Yazdi H & Isotalo PA 2000 Resection margin status in lumpectomy specimens of infiltrating lobular carcinoma. Breast Cancer Research and Treatment6029\u201333.","DOI":"10.1023\/A:1006359308505"},{"key":"2026070906041704700_MATE-ETAL-1986","doi-asserted-by":"crossref","unstructured":"Mate\n            TP\n          , Carter D, Fischer DB, Hartman PV, McKhann C, Merino M, Prosnitz LR & Weisseberg JB 1986 A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast cancer. Cancer581995\u20132002.","DOI":"10.1002\/1097-0142(19861101)58:9<1995::AID-CNCR2820580907>3.0.CO;2-1"},{"key":"2026070906041704700_MATHIEU-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Mathieu\n            MC\n          , Rouzier R, Llombart-Cussac A, Sideris L, Koscielny S, Travagli JP, Contesso G, Delaloge S & Spielmann M 2004 The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. European Journal of Cancer40342\u2013351.","DOI":"10.1016\/j.ejca.2003.08.015"},{"key":"2026070906041704700_MENDELSON-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Mendelson\n            EB\n          , Harris KM, Doshu N & Tobon H 1989 Infiltrating lobular carcinoma:mammographic patterns with pathologic correlation. American Journal of Roentgenology153265\u2013271.","DOI":"10.2214\/ajr.153.2.265"},{"key":"2026070906041704700_MERSIN-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Mersin\n            H\n          , Yildirim E, Gulben K & Berberoglu U 2003 Is invasive lobular carcinoma different form invasive ductal carcinoma? European Journal of Surgical Oncology29390\u2013395.","DOI":"10.1053\/ejso.2002.1423"},{"key":"2026070906041704700_MOLLAND-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Molland\n            JG\n          , Donnellan M, Janu NC, Carmalt HL, Kennedy CW & Gillett DJ 2004 Infiltrating lobular carcinoma \u2013 a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast13389\u2013396.","DOI":"10.1016\/j.breast.2004.03.004"},{"key":"2026070906041704700_NEWCOMB-ETAL-2002","unstructured":"Newcomb\n            PA\n          , Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC & Stampfer MJ 2002 Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention11593\u2013600."},{"key":"2026070906041704700_NEWCOMER-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Newcomer\n            LM\n          , Newcomb PA, Daling JR, Yasui Y & Potter JD 2003 Post-menopausal hormone use and risk of breast cancer by histologic type (United States). Cancer Causes and Control14225\u2013233.","DOI":"10.1023\/A:1023634907723"},{"key":"2026070906041704700_PAPPO-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Pappo\n            I\n          , Meirshon I, Karni T, Siegelmann-Danielli N, Stahl-Kent V, Sandbank J, Wasserman I & Halevy A 2004 The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers. Annals of Surgical Oncology1152\u201358.","DOI":"10.1007\/BF02524346"},{"key":"2026070906041704700_PARAMAGUL-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Paramagul\n            CP\n          , Helvie MA & Adler DD 1995 Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology195231\u2013234.","DOI":"10.1148\/radiology.195.1.7892476"},{"key":"2026070906041704700_PARK-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Park\n            CC\n          , Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR et al.2000 Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. Journal of Clinical Oncology181668\u20131675.","DOI":"10.1200\/JCO.2000.18.8.1668"},{"key":"2026070906041704700_PEIRO-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Peiro\n            G\n          , Bornstein BA, Connolly JL, Gelman R, Hetelekidis S, Nixon AJ, Recht A, Silver B, Harris JR & Schnitt SJ 2000 The influence on infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Research and Treatment5949\u201354.","DOI":"10.1023\/A:1006384407690"},{"key":"2026070906041704700_PERSSON-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Persson\n            I\n          , Yuen J, Bergkvist L & Schairer C 1996 Cancer incidence and mortality in women receiving estrogen and estrogen\u2013progestin replacement therapy \u2013 long-term follow-up of a Swedish cohort. International Journal of Cancer67337\u2013332.","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T"},{"key":"2026070906041704700_POEN-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Poen\n            JC\n          , Tran L, Juillard G, Selch MT, Giuliano A, Silverstein M, Fingerhut A, Lewinsky B & Parker RG 1992 Conservation therapy for invasive lobular carcinoma of the breast. Cancer692789\u20132795.","DOI":"10.1002\/1097-0142(19920601)69:11<2789::AID-CNCR2820691126>3.0.CO;2-J"},{"key":"2026070906041704700_POINTON-AND-CUNNINGHAM-1999","doi-asserted-by":"crossref","unstructured":"Pointon\n            KS\n           & Cunningham DA 1999 Ultrasound findings in pure invasive lobular carcinoma of the breast: comparison with matched cases of invasive ductal carcinoma of the breast. Breast8188\u2013190.","DOI":"10.1054\/brst.1999.0042"},{"key":"2026070906041704700_POLEDNAK-2003","doi-asserted-by":"crossref","unstructured":"Polednak\n            A\n          \n          2003 Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival. Surgery133383\u2013389.","DOI":"10.1067\/msy.2003.110"},{"key":"2026070906041704700_POOLE-ETAL-2006","unstructured":"Poole\n            AJ\n          , Li Y, Kim Y, Lin SC, Lee WH & Lee EY 2006 Prevention of BRCA1-mediated mammary tumorigenesis in mice by progesterone antagonist. Science3141467\u20131470."},{"key":"2026070906041704700_QUAN-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Quan\n            ML\n          , Sclafani L, Heerdt S, Fey JV, Morris EA & Borgen PI 2003 Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Annals of Surgical Oncology101048\u20131053.","DOI":"10.1245\/ASO.2003.03.016"},{"key":"2026070906041704700_REEVES-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Reeves\n            GK\n          , Beral V, Green J, Gathani T, Bull D & Million Women Study Collaborators 2006 Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. LancetOncology7910\u2013918.","DOI":"10.1016\/S1470-2045(06)70911-1"},{"key":"2026070906041704700_RISSANEN-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Rissanen\n            T\n          , Tikkakoski T, Autio AL & Apaja-Sarkkinen M 1998 Ultrasonography of invasive lobular breast carcinoma. Acta Radiologica39285\u2013291.","DOI":"10.3109\/02841859809172196"},{"key":"2026070906041704700_RODENKO-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Rodenko\n            GN\n          , Harms SE, Pruneda JM, Farell RS, Evans WP, Copit DS, Krakos PA & Flamig DP 1996 MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. American Journal of Roentgenology1671415\u20131419.","DOI":"10.2214\/ajr.167.6.8956569"},{"key":"2026070906041704700_ROSEN-2001","unstructured":"Rosen\n            PP\n          \n          2001 Invasive lobular cancer. In Rosen\u2019s Pathology of the Breast, pp 629\u2013637. Ed PP Rosen. New York: Lippincott Williams & Wilkins."},{"key":"2026070906041704700_ROSS-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Ross\n            RK\n          , Paganini-Hill A, Wan PC & Pike MC 2000 Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Journal of the National Cancer Institute92328\u2013332.","DOI":"10.1097\/00006254-200007000-00022"},{"key":"2026070906041704700_ROSSOUW-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Rossouw\n            JE\n          , Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC & Writing Group for the Women\u2019s Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA288321\u2013333.","DOI":"10.1001\/jama.288.3.321"},{"key":"2026070906041704700_ROUZIER-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Rouzier\n            R\n          , Mathieu M, Sideris L, Youmsi E, Rajan R, Garbay J, Andre\u0300 F, Marsiglia H, Spielmann M & Delaloge S 2004 Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors. Cancer101918\u2013925.","DOI":"10.1002\/cncr.20491"},{"key":"2026070906041704700_SALVADORI-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Salvadori\n            B\n          , Biganzoli E, Veronesi P, Saccozzi R & Rilke F 1997 Conservative surgery for infiltrating lobular breast carcinoma. British Journal of Surgery84106\u2013109.","DOI":"10.1046\/j.1365-2168.1997.02540.x"},{"key":"2026070906041704700_SANTIAGO-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Santiago\n            RJ\n          , Harris EE, Qinj L, Hwang WT & Solin LJ 2005 Similar long-term results of breast \u2013 conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience. Cancer1032447\u20132554.","DOI":"10.1002\/cncr.21071"},{"key":"2026070906041704700_SASTRE-GARAU-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Sastre-Garau\n            X\n          , Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand J, Fourquet A & Pouillart P 1996 Infiltrating lobular carcinoma of the breast. Clinicopathological analysis of 975 cases with references to data on conservative therapy and metastatic patterns. Cancer77113\u2013120.","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8"},{"key":"2026070906041704700_SCHAIRER-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Schairer\n            C\n          , Lubin J, Troisi R, Sturgeon S, Brinton L & Hoover R 2000 Menopausal estrogen and estrogen\u2013progestin replacement therapy and breast cancer risk. JAMA283485\u2013491.","DOI":"10.1001\/jama.284.6.691-f"},{"key":"2026070906041704700_SCHELFOUT-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Schelfout\n            K\n          , Van Goethem M & Kersschot E 2004 Preoperative breast MRI in patients with invasive lobular breast cancer. European Radiology141209\u20131216.","DOI":"10.1007\/s00330-004-2275-7"},{"key":"2026070906041704700_SCHNITT-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Schnitt\n            SJ\n          , Connolly JL, Recht A, Silver B & Harris JR 1989 Influence of infiltrating lobular histology on local tumour control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer64448\u2013454.","DOI":"10.1002\/1097-0142(19890715)64:2<448::AID-CNCR2820640218>3.0.CO;2-7"},{"key":"2026070906041704700_SILVERSTEIN-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Silverstein\n            MJ\n          , Lewinsky BS, Waisman JR, Glerson ED, Colburn WJ, Senofsky GM & Gamagani P 1994 Infiltrating lobular carcinoma: is it different from infiltrating duct carcinoma? Cancer731673\u20131677.","DOI":"10.1002\/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B"},{"key":"2026070906041704700_SINGLETARY-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Singletary\n            SE\n          , Patel-Parekh L & Bland KI 2005 Treatment trends in early-stage invasive lobular carcinoma. A report from the National Cancer Data Base. Annals of Surgery242281\u2013289.","DOI":"10.1097\/01.sla.0000171306.74366.22"},{"key":"2026070906041704700_STEFANICK-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Stefanick\n            ML\n          , Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, Lane DS, Hubbell FA, Assaf AR, Sarto GE et al.2006 Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA2951647\u20131657.","DOI":"10.1001\/jama.295.14.1647"},{"key":"2026070906041704700_TOIKKANEN-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Toikkanen\n            S\n          , Pylkkanen L & Joensuu H 1997 Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. British Journal of Cancer761234\u20131240.","DOI":"10.1038\/bjc.1997.540"},{"key":"2026070906041704700_TRESSERRA-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Tresserra\n            F\n          , Feu J, Grases PJ, Navarro B, Alegret X & Fernandez-Cid A 1999 Assessment of breast cancer size: sonographic and pathologic correlation. Journal of Clinical Ultrasound27485\u2013491.","DOI":"10.1002\/(SICI)1097-0096(199911\/12)27:9<485::AID-JCU1>3.0.CO;2-C"},{"key":"2026070906041704700_TUBIANA-HULIN-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Tubiana-Hulin\n            M\n          , Stevens D, Lasry S, Guinebretiere JM, Bouita L, Cohen-Solal C, Cherel P & Rouesse J 2006 Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. Annals of Oncology171228\u20131233.","DOI":"10.1093\/annonc\/mdl114"},{"key":"2026070906041704700_TUTTLE-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Tuttle\n            TM\n          , Colbert M, Christensen R, Ose KJ, Jones T, Wetherille R, Friedman J, Swenson K & McMasters KM 2002 Subareolar injection of 99mTc facilitates sentinel lymph node identification. Annals of Surgical Oncology977\u201381.","DOI":"10.1245\/aso.2002.9.1.77"},{"key":"2026070906041704700_UGNAT-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Ugnat\n            AM\n          , Xie L, Morriss J, Semenciw R & Mao Y 2004 Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. British Journal of Cancer901138\u20131143.","DOI":"10.1038\/sj.bjc.6601662"},{"key":"2026070906041704700_VELTMAN-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Veltman\n            J\n          , Boetes C, van Die L, Bult P, Blickman JG & Barentsz JO 2006 Mammographic detection and staging of invasive lobular carcinoma. Clinical Imaging3094\u201398.","DOI":"10.1016\/j.clinimag.2005.09.021"},{"key":"2026070906041704700_VO-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Vo\n            TN\n          , Meric Bernstam F, Yi M, Buchholtz TA, Ames FC, Kueree HM, Bedrosian I & Hunt KK 2006 Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. American Journal of Surgery192552\u2013555.","DOI":"10.1016\/j.amjsurg.2006.06.020"},{"key":"2026070906041704700_WARNEKE-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Warneke\n            J\n          , Berger R, Johnson C, Stea D & Villar H 1996 Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast. American Journal of Surgery172496\u2013500.","DOI":"10.1016\/S0002-9610(96)00227-9"},{"key":"2026070906041704700_WATSON-2001","unstructured":"Watson\n            L\n          \n          2001 Breast cancer: diagnosis, treatment and prognosis. Radiologic Technology7345\u201361."},{"key":"2026070906041704700_WEISS-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Weiss\n            ML\n          , Fowble BL, Solin LJ, Tien Yeh I & Schultz DJ 1992 Outcome of conservative therapy for invasive breast cancer by histologic subtype. International Journal of Radiation Oncology, Biology, Physics23941\u2013947.","DOI":"10.1016\/0360-3016(92)90898-R"},{"key":"2026070906041704700_WEISS-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Weiss\n            LK\n          , Burkman RT, Cushing-Haugen KL, Voigt LF, Simon MS, Daling JR, Norman SA, Bernstein L, Ursin G & Marchbanks PA 2002 Hormone replacement therapy regimens and breast cancer risk. Obstetrics and Gynecology1001148\u20131158.","DOI":"10.1097\/00006250-200212000-00003"},{"key":"2026070906041704700_WHITE-ETAL-1994","doi-asserted-by":"crossref","unstructured":"White\n            JR\n          , Gustafson GS, Wimbish K, Ingold JA, Lucas RJ, Levine AJ, Matter RA, Martinez A & Vicini FA 1994 Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. Cancer74640\u2013647.","DOI":"10.1002\/1097-0142(19940715)74:2<640::AID-CNCR2820740216>3.0.CO;2-V"},{"key":"2026070906041704700_WINCHESTER-ETAL-1998","unstructured":"Winchester\n            DJ\n          , Chang HR, Graves TA, Menck HR, Bland KI & Winchester DP 1998 A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. Journal of the American College of Surgeons186416\u2013422."},{"key":"2026070906041704700_WYSOWSKI-AND-GOVERNALE-2005","doi-asserted-by":"crossref","unstructured":"Wysowski\n            DK\n           & Governale LA 2005 Use of menopausal hormones in the United States, 1992 through June, 2003. Pharmacoepidemiology and Drug Safety14171\u2013176.","DOI":"10.1002\/pds.985"},{"key":"2026070906041704700_WYSOWSKI-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Wysowski\n            DK\n          , Golden L & Burke L 1995 Use of menopausal estrogens and medroxyprogesterone in the United States, 1982\u20131992. Obstetrics and Gynecology856\u201310.","DOI":"10.1016\/0029-7844(94)00339-F"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/14\/3\/0140549.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/14\/3\/549\/150893\/0140549.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/14\/3\/549\/150893\/0140549.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:04:34Z","timestamp":1783591474000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/14\/3\/549\/26836\/Increased-incidence-of-lobular-breast-cancer-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.1677\/erc-06-0060","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}